Location: New York, NY
CIK: 0001746382 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value: $299M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,000 | $11.84M | 4.0% | $27.51 | +2.4% | Call | 74366E102 |
| ESPR | ESPERION THERAPEUTICS INC NE | 2,496,524 | $11.58M | 3.9% | $8.01 | -46.4% | COM | 29664W105 |
| — | BELLUS HEALTH INC NEW | 1,450,006 | $9.976M | 3.3% | $3.07 | — | COM NEW | 07987C204 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 386,000 | $9.14M | 3.1% | $27.51 | +2.4% | COM | 74366E102 |
| — | CHINOOK THERAPEUTICS INC | 545,000 | $8.916M | 3.0% | $14.98 | — | COM | 16961L106 |
| — | PEPPERLIME HEALTH ACQUSTN CO | 735,000 | $7.232M | 2.4% | $9.84 | — | UNIT 99/99/9999 | G70021129 |
| KROS | KEROS THERAPEUTICS INC | 126,000 | $6.852M | 2.3% | $36.84 | +39.3% | COM | 492327101 |
| DXCM | DEXCOM INC | 12,500 | $6.395M | 2.1% | $109.39 | 0.0% | COM | 252131107 |
| — | QUIDEL CORP | 56,000 | $6.298M | 2.1% | $127.35 | — | COM | 74838J101 |
| INSM | INSMED INC | 268,000 | $6.298M | 2.1% | $30.94 | -24.9% | COM PAR $.01 | 457669307 |
| ADMA | ADMA BIOLOGICS INC | 3,300,000 | $6.039M | 2.0% | $1.31 | +18.7% | COM | 000899104 |
| GMED | GLOBUS MED INC | 79,000 | $5.829M | 2.0% | $67.21 | +3.4% | CL A | 379577208 |
| TNDM | TANDEM DIABETES CARE INC | 50,000 | $5.815M | 1.9% | $116.75 | 0.0% | COM NEW | 875372203 |
| — | NEVRO CORP | 77,000 | $5.569M | 1.9% | $103.00 | — | COM | 64157F103 |
| RLMD | RELMADA THERAPEUTICS INC | 206,000 | $5.56M | 1.9% | $22.24 | -7.0% | COM | 75955J402 |
| — | CYMABAY THERAPEUTICS INC | 1,750,000 | $5.443M | 1.8% | $3.38 | — | COM | 23257D103 |
| GKOS | GLAUKOS CORP | 94,000 | $5.435M | 1.8% | $47.09 | +12.4% | COM | 377322102 |
| BCYC | BICYCLE THERAPEUTICS PLC | 120,000 | $5.266M | 1.8% | $50.56 | — | SPONSORED ADS | 088786108 |
| NVST | ENVISTA HOLDINGS CORPORATION | 105,000 | $5.115M | 1.7% | $46.13 | 0.0% | COM | 29415F104 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $5.04M | 1.7% | $9.86 | — | ORDINARY SHARES | G6580S114 |
| — | SHOCKWAVE MED INC | 23,000 | $4.769M | 1.6% | $207.35 | — | COM | 82489T104 |
| — | KARYOPHARM THERAPEUTICS INC | 645,000 | $4.754M | 1.6% | $7.37 | — | COM | 48576U106 |
| — | QIAGEN NV | 93,000 | $4.557M | 1.5% | $55.58 | — | SHS NEW | N72482123 |
| RNAM | AVIDITY BIOSCIENCES INC | 243,000 | $4.488M | 1.5% | $23.46 | -27.6% | COM | 05370A108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 204,000 | $4.478M | 1.5% | $19.08 | +6.1% | COM | 22663K107 |
| — | IMMUNOGEN INC | 920,000 | $4.379M | 1.5% | $4.76 | — | COM | 45253H101 |
| XTNT | XTANT MED HLDGS INC | 6,246,291 | $4.247M | 1.4% | $1.78 | -63.2% | COM NEW | 98420P308 |
| — | VERASTEM INC | 2,951,000 | $4.161M | 1.4% | $2.13 | — | COM | 92337C104 |
| INSP | INSPIRE MED SYS INC | 16,000 | $4.107M | 1.4% | $200.46 | +14.0% | COM | 457730109 |
| LIVN | LIVANOVA PLC | 50,000 | $4.092M | 1.4% | $77.76 | 0.0% | SHS | G5509L101 |
| — | IVERIC BIO INC | 236,000 | $3.972M | 1.3% | $6.91 | — | COM | 46583P102 |
| — | EUCRATES BIOMEDICAL ACQU COR | 400,000 | $3.936M | 1.3% | $9.85 | — | SHS | G3141W106 |
| ILMN | ILLUMINA INC | 11,000 | $3.843M | 1.3% | $360.66 | -6.3% | COM | 452327109 |
| POLWQ | 1847 GOEDEKER INC | 6,103,824 | $3.778M | 1.3% | $2.14 | — | *W EXP 06/02/202 | 28252C117 |
| — | EIGER BIOPHARMACEUTICALS INC | 440,000 | $3.652M | 1.2% | $9.64 | — | COM | 28249U105 |
| OCUL | OCULAR THERAPEUTIX INC | 695,000 | $3.44M | 1.2% | $11.99 | -53.8% | COM | 67576A100 |
| IMUX | IMMUNIC INC | 300,000 | $3.39M | 1.1% | $9.01 | +28.5% | COM | 4525EP101 |
| — | ADICET BIO INC | 155,000 | $3.095M | 1.0% | $15.10 | — | COM | 007002108 |
| MYGN | MYRIAD GENETICS INC | 114,710 | $2.891M | 1.0% | $18.31 | +39.8% | COM | 62855J104 |
| KRMD | REPRO MED SYS INC | 995,500 | $2.847M | 1.0% | $3.75 | -20.2% | COM | 759910102 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 224,541 | $2.728M | 0.9% | $10.89 | +0.7% | COM NEW | 30233G209 |
| — | KARUNA THERAPEUTICS INC | 21,000 | $2.663M | 0.9% | $126.81 | — | COM | 48576A100 |
| — | TURMERIC ACQUISITION CORP | 254,000 | $2.502M | 0.8% | $9.89 | — | CL A | G9127T108 |
| — | MORPHIC HLDG INC | 60,000 | $2.409M | 0.8% | $61.12 | — | COM | 61775R105 |
| — | OUTSET MED INC | 52,007 | $2.361M | 0.8% | $45.40 | — | COM | 690145107 |
| HLMN | HILLMAN SOLUTIONS CORP | 196,000 | $2.328M | 0.8% | $11.58 | -15.0% | COM | 431636109 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 66,000 | $2.248M | 0.8% | $34.82 | -8.2% | COM NEW | 15117B202 |
| — | SARISSA CAPITAL ACQUISITN CO | 225,000 | $2.228M | 0.7% | $9.86 | — | CL A | G7823W102 |
| LNTH | LANTHEUS HLDGS INC | 40,000 | $2.212M | 0.7% | $15.53 | +141.7% | COM | 516544103 |
| SLN | SILENCE THERAPEUTICS PLC | 109,000 | $2.071M | 0.7% | $19.00 | — | ADS | 82686Q101 |
| — | CARA THERAPEUTICS INC | 165,000 | $2.005M | 0.7% | $12.15 | — | COM | 140755109 |
| — | TG VENTURE ACQUISITION CORP | 200,000 | $2.004M | 0.7% | $10.25 | — | UNIT 08/15/2028 | 87251T208 |
| — | GIGINTERNATIONAL1 INC | 200,000 | $2M | 0.7% | $9.87 | — | COM | 37518W106 |
| — | LAKESHORE ACQUISITION I CORP | 200,000 | $1.982M | 0.7% | $9.83 | — | ORDINARY SHARES | G53521103 |
| — | CHAVANT CAPITAL ACQUISITN CO | 200,000 | $1.982M | 0.7% | $9.85 | — | ORDINARY SHARES | G2058L103 |
| — | JIYA ACQUISITION CORP | 200,000 | $1.966M | 0.7% | $10.30 | — | COM CL A | 47760M102 |
| — | 2SEVENTY BIO INC | 115,000 | $1.962M | 0.7% | $17.06 | — | COMMON STOCK | 901384107 |
| ALT | ALTIMMUNE INC | 322,000 | $1.961M | 0.7% | $7.36 | 0.0% | COM NEW | 02155H200 |
| AGIO | AGIOS PHARMACEUTICALS INC | 66,196 | $1.927M | 0.6% | $30.55 | 0.0% | COM | 00847X104 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 54,000 | $1.871M | 0.6% | $29.28 | — | COM | 37890U108 |
| — | PARDES BIOSCIENCES INC | 253,000 | $1.827M | 0.6% | $14.45 | — | COM | 69945Q105 |
| CTMX | CYTOMX THERAPEUTICS INC | 663,800 | $1.772M | 0.6% | $6.93 | -44.6% | COM | 23284F105 |
| — | RENOVACOR INC | 388,845 | $1.649M | 0.6% | $9.05 | — | COM | 75989E106 |
| PRCT | PROCEPT BIOROBOTICS CORP | 47,077 | $1.647M | 0.6% | $24.07 | 0.0% | COM | 74276L105 |
| — | DIGITAL HEALTH ACQUISITION C | 150,000 | $1.515M | 0.5% | $10.24 | — | UNIT 11/02/2026 | 253893200 |
| — | AULT DISRUPTIVE TECHS CORP | 150,000 | $1.496M | 0.5% | $9.97 | — | COM | 05150A104 |
| — | SOMALOGIC INC | 180,000 | $1.444M | 0.5% | $8.02 | — | CLASS A COM | 83444K105 |
| — | CTI BIOPHARMA CORP | 299,800 | $1.4M | 0.5% | $2.62 | — | COM | 12648L601 |
| — | INTRA-CELLULAR THERAPIES INC | 22,500 | $1.377M | 0.5% | $61.20 | — | COM | 46116X101 |
| — | CURIS INC | 540,800 | $1.287M | 0.4% | $8.18 | — | COM NEW | 231269200 |
| — | TAILWIND ACQUISITION CORP | 128,414 | $1.271M | 0.4% | $9.92 | — | COM CL A | 87403Q102 |
| PROF | PROFOUND MED CORP | 124,945 | $1.125M | 0.4% | $19.27 | -50.0% | COM NEW | 74319B502 |
| — | CUTERA INC | 15,000 | $1.035M | 0.3% | $69.00 | — | COM | 232109108 |
| — | FAT BRANDS INC | 227,000 | $1.022M | 0.3% | $2.70 | — | *W EXP 07/16/202 | 30258N121 |
| — | MURPHY CANYON ACQUISITION CO | 100,000 | $1.01M | 0.3% | $10.10 | — | UNIT 01/25/2027 | 626642201 |
| — | RELATIVITY ACQUISITION CORP | 100,000 | $1.007M | 0.3% | $10.07 | — | UNIT 02/10/2027 | 75944B205 |
| — | INDUSTRIAL HUMAN CAPITAL INC | 100,000 | $1.002M | 0.3% | $9.92 | — | COM | 45617P104 |
| — | WESTERN ACQSTN VENTURES CORP | 100,000 | $1M | 0.3% | $10.00 | — | UNIT 09/01/2026 | 95758L206 |
| — | BCLS ACQUISITION CORP | 100,000 | $987K | 0.3% | $11.14 | — | COM CL A | G0904B105 |
| — | OMEGA ALPHA SPAC | 100,000 | $982K | 0.3% | $9.90 | — | CL A | G6749V107 |
| — | OPY ACQUISITION CORP I | 100,000 | $980K | 0.3% | $9.80 | — | COM CL A | 671005106 |
| — | ARYA SCIENCES ACQU CORP IV | 100,000 | $980K | 0.3% | $9.92 | — | CL A | G31659108 |
| — | MUSCLE MAKER INC | 1,796,961 | $948K | 0.3% | $0.72 | — | COM | 627333107 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 122,000 | $924K | 0.3% | $9.52 | -21.8% | COM | 004468500 |
| — | COLISEUM ACQUISITION CORP | 85,000 | $825K | 0.3% | $9.95 | — | CLASS A ORD SHS | G2263T123 |
| VQSSF | VIQ SOLUTIONS INC | 489,417 | $798K | 0.3% | $5.22 | -63.1% | COM NEW | 91825V400 |
| — | VERRICA PHARMACEUTICALS INC | 97,887 | $794K | 0.3% | $14.45 | — | COM | 92511W108 |
| DDI | DOUBLEDOWN INTERACTIVE CO LT | 60,876 | $722K | 0.2% | $17.61 | — | ADS | 25862B109 |
| — | GSR II METEORA ACQUISITN COR | 50,000 | $506K | 0.2% | $10.12 | — | UNIT 02/24/2027 | 36263W204 |
| — | COLOMBIER ACQUISITION CORP | 50,000 | $484K | 0.2% | $9.68 | — | CL A | 19533H108 |
| TCBWF | TC BIOPHARM HOLDINGS PLC | 941,176 | $461K | 0.2% | $0.49 | — | *W EXP 02/08/202 | 87807D111 |
| — | LIGHTNING EMOTORS INC | 652,173 | $268K | 0.1% | $0.41 | — | *W EXP 05/18/202 | 53228T119 |
| — | RENOVACOR INC | 731,561 | $249K | 0.1% | $0.68 | — | *W EXP 99/99/999 | 75989E114 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 650,000 | $240K | 0.1% | $0.77 | — | *W EXP 10/04/202 | 41150T124 |
| — | SURGEPAYS INC | 250,000 | $223K | 0.1% | $0.64 | — | *W EXP 10/22/202 | 86882L113 |
| — | IMMATICS N.V | 97,467 | $171K | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 600,000 | $171K | 0.1% | $0.63 | — | *W EXP 05/09/202 | 41150T116 |
| BNCWW | CEA INDUSTRIES INC | 250,000 | $171K | 0.1% | $0.68 | — | *W EXP 02/11/202 | 86887P119 |
| — | PEPPERLIME HEALTH ACQUSTN CO | 367,500 | $152K | 0.1% | $0.45 | — | *W EXP 10/01/202 | G70021111 |
| — | DIRECT DIGITAL HOLDINGS INC | 180,000 | $131K | 0.0% | $0.73 | — | *W EXP 02/15/202 | 25461T113 |
| CINGW | CINGULATE INC | 270,000 | $108K | 0.0% | $0.71 | — | *W EXP 12/03/202 | 17248W113 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $105K | 0.0% | $0.38 | — | RIGHT 12/26/2025 | G6580S106 |
| — | HEALTH SCIENCES ACQ CORP 2 | 10,000 | $99,000 | 0.0% | $12.80 | — | ORD SHS | G4411D109 |
| NXGLW | NEXGEL INC | 225,000 | $88,000 | 0.0% | $0.81 | — | *W EXP 12/01/202 | 65344E115 |
| — | CALITHERA BIOSCIENCES INC | 202,276 | $82,000 | 0.0% | $0.41 | — | COM | 13089P101 |
| — | NLS PHARMACEUTICS LTD | 200,000 | $76,000 | 0.0% | $0.73 | — | *W EXP 09/25/202 | H57830111 |
| — | LAKESHORE ACQUISITION I CORP | 150,000 | $53,000 | 0.0% | $0.53 | — | *W EXP 07/15/202 | G53521111 |
| — | CHAVANT CAPITAL ACQUISITN CO | 150,000 | $30,000 | 0.0% | $0.48 | — | *W EXP 99/99/999 | G2058L111 |
| — | SARISSA CAPITAL ACQUISITN CO | 75,000 | $27,000 | 0.0% | $1.00 | — | *W EXP 10/23/202 | G7823W110 |
| — | EUCRATES BIOMEDICAL ACQU COR | 133,333 | $25,000 | 0.0% | $1.04 | — | *W EXP 10/23/202 | G3141W122 |
| — | TURMERIC ACQUISITION CORP | 84,666 | $24,000 | 0.0% | $0.92 | — | *W EXP 10/08/202 | G9127T124 |
| SRZNW | SURROZEN INC | 82,233 | $21,000 | 0.0% | $1.14 | — | *W EXP 08/01/203 | 86889P117 |
| — | OPY ACQUISITION CORP I | 50,000 | $20,000 | 0.0% | $0.40 | — | *W EXP 09/22/202 | 671005114 |
| — | AULT DISRUPTIVE TECHS CORP | 112,500 | $19,000 | 0.0% | $0.17 | — | *W EXP 99/99/999 | 05150A112 |
| — | GIGINTERNATIONAL1 INC | 50,000 | $18,000 | 0.0% | $0.74 | — | *W EXP 04/19/202 | 37518W114 |
| — | INDUSTRIAL HUMAN CAPITAL INC | 100,000 | $18,000 | 0.0% | $0.38 | — | *W EXP 11/27/202 | 45617P112 |
| — | COLISEUM ACQUISITION CORP | 28,333 | $10,000 | 0.0% | $0.81 | — | *W EXP 08/22/202 | G2263T107 |
| — | COLOMBIER ACQUISITION CORP | 16,666 | $5,000 | 0.0% | $0.54 | — | *W EXP 99/99/999 | 19533H116 |